Literature DB >> 10684293

The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells.

P T Lieu1, E K Wagner.   

Abstract

We generated recombinant viruses in which the kinetics of expression of the leaky-late VP5 mRNA was altered. We then analyzed the effect of such alterations on viral replication in cultured cells. The VP5 promoter and leader sequences from positions -36 to +20, containing the TATA box and an initiator element, were deleted and replaced with a strong early (dUTPase), an equal-strength leaky-late (VP16), or a strict-late (U(L)38) promoter. We found that recombinant viruses containing the dUTPase promoter inserted in the VP5 locus expressed VP5-encoding mRNA with early kinetics, while virus with the U(L)38 promoter inserted expressed such mRNA with strict-late kinetics. Further, in spite of differences in its functional architecture, the VP16 promoter fully substituted for the VP5 promoter. Western blot analysis demonstrated that the amounts of VP5 capsid protein produced by the recombinant viruses differed somewhat; however, on complementing C32 and noncomplementing Vero cells, such viruses replicated to titers equivalent to those of the rescued wild-type virus controls. Multistep virus growth in mouse embryo fibroblasts, rabbit skin cells, and Vero cells also demonstrated equivalent replication efficiencies for both recombinant and wild-type viruses. Further, recombinant viruses did not show any impairment in their ability to replicate on serum-starved or quiescent human lung fibroblasts. We conclude that the kinetics of the essential VP5 mRNA expression is not critical for viral replication in cultured cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684293      PMCID: PMC111767          DOI: 10.1128/jvi.74.6.2770-2776.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Transcriptional and post-transcriptional controls establish the cascade of herpes simplex virus protein synthesis.

Authors:  S P Weinheimer; S L McKnight
Journal:  J Mol Biol       Date:  1987-06-20       Impact factor: 5.469

2.  Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.

Authors:  C I Ace; T A McKee; J M Ryan; J M Cameron; C M Preston
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation.

Authors:  P J Godowski; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 4.  Restriction endonuclease patterns of herpes simplex virus DNA: application to diagnosis and molecular epidemiology.

Authors:  B Roizman; M Tognon
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  gamma 2-Thymidine kinase chimeras are identically transcribed but regulated a gamma 2 genes in herpes simplex virus genomes and as beta genes in cell genomes.

Authors:  S Silver; B Roizman
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

6.  Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases.

Authors:  R Jordan; L Schang; P A Schaffer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 7.  HSV gene functions: what have we learned that could be generally applicable to its near and distant cousins?

Authors:  B Roizman
Journal:  Acta Virol       Date:  1999 Apr-Jun       Impact factor: 1.162

8.  The exchange of cognate TATA boxes results in a corresponding change in the strength of two HSV-1 early promoters.

Authors:  P T Lieu; N T Pande; M K Rice; E K Wagner
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

9.  Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction.

Authors:  T Takasu; Y Furuta; K C Sato; S Fukuda; Y Inuyama; K Nagashima
Journal:  Acta Otolaryngol       Date:  1992-11       Impact factor: 1.494

10.  Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product.

Authors:  R M Sandri-Goldin; A L Goldin; L E Holland; J C Glorioso; M Levine
Journal:  Mol Cell Biol       Date:  1983-11       Impact factor: 4.272

View more
  8 in total

1.  Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray.

Authors:  S W Stingley; J J Ramirez; S A Aguilar; K Simmen; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.

Authors:  Qingsong Qin; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

4.  The TATGARAT box of the HSV-1 ICP27 gene is essential for immediate early expression but not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Wagner; E K Wager
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.332

5.  Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice.

Authors:  Robert K Tran; Pauline T Lieu; Santiago Aguilar; Edward K Wagner; David C Bloom
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  UBE1a Suppresses Herpes Simplex Virus-1 Replication.

Authors:  Marina Ikeda; Akihiro Ito; Yuichi Sekine; Masahiro Fujimuro
Journal:  Viruses       Date:  2020-12-04       Impact factor: 5.048

7.  De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.

Authors:  Richard L Thompson; Chris M Preston; Nancy M Sawtell
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

8.  Dimethyl sulfoxide blocks herpes simplex virus-1 productive infection in vitro acting at different stages with positive cooperativity. Application of micro-array analysis.

Authors:  J S Aguilar; D Roy; P Ghazal; E K Wagner
Journal:  BMC Infect Dis       Date:  2002-05-24       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.